학술논문
Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
Document Type
Article
Author
Source
In: Journal of Clinical Investigation . (Journal of Clinical Investigation, 2 November 2020, 130(11):6041-6053)
Subject
Language
English
ISSN
15588238
00219738
00219738